Transient Ischemic Attack (TIA) Clinical Trials

Find Transient Ischemic Attack (TIA) Clinical Trials Near You

Diagnosis of Transient Ischemic Attacks in the Emergency Department

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Patients presenting a Transient Ischemic Attack (TIA) and admitted to the Emergency Department should be referred to a neurovascular specialist. In recent years, several hospitals have established TIA clinics. These units are day hospitals where all the necessary examinations are performed. Access to this expertise has proven beneficial in reducing cardiovascular morbidity and mortality, particularly the risk of early recurrence. Unfortunately, this access is limited by issues of medical demographics and unequal access to the healthcare system. In practice, this ideal care is not always possible. A portion of the TIA population is at low risk, and diagnostic and therapeutic interventions are limited, not always requiring neurovascular expertise. The hypothesis of this research is that the management of a patient who has suffered a TIA (additional examinations, treatment, referral) is not linked to their cardiovascular risk and that the performance of additional examinations and therapies is incomplete.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult (≥18 years old)

• Having consulted the emergency department or been diagnosed with TIA during the period from January 1, 2024, to December 12, 2024 (records will be compiled via coding at the East Rescue regional emergency observatory)

• TIA will be defined as a sudden, transient neurological deficit that had disappeared by the time of arrival at the emergency department

Locations
Other Locations
France
Service d'Urgences Médico-Chirurgicales Adules - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Pierrick LE BORGNE, MD
Pierrick.LEBORGNE@chru-strasbourg.fr
33 3.88.12.86.90
Backup
Mathieu OBERLIN, MD
mathieu.oberlin@ghso.fr
33 6.72.07.23.60
Time Frame
Start Date: 2025-02-06
Estimated Completion Date: 2027-01-06
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov